There is no formal primary prevention program in the US.
Most cases of prostate cancer cannot be prevented. However, risk may be reduced by addressing lifestyle factors, such as poor diet and being overweight.
Chemoprevention
The role of 5-alpha-reductase inhibitors in preventing prostate cancer has been investigated, but remains controversial. Chemoprevention with finasteride and dutasteride reduces risk of prostate cancer by approximately 20% to 25%.[37]Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003 Jul 17;349(3):215-24.
http://www.nejm.org/doi/full/10.1056/NEJMoa030660#t=article
http://www.ncbi.nlm.nih.gov/pubmed/12824459?tool=bestpractice.com
[38]Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 1;362(13):1192-202.
https://www.doi.org/10.1056/NEJMoa0908127
http://www.ncbi.nlm.nih.gov/pubmed/20357281?tool=bestpractice.com
Long-term analyses found continued risk-reduction benefit in those treated with finasteride.[39]Unger JM, Hershman DL, Till C, et al. Using medicare claims to examine long-term prostate cancer risk of finasteride in the Prostate Cancer Prevention trial. J Natl Cancer Inst. 2018 Nov 1;110(11):1208-15.
https://www.doi.org/10.1093/jnci/djy035
http://www.ncbi.nlm.nih.gov/pubmed/29534197?tool=bestpractice.com
[40]Goodman PJ, Tangen CM, Darke AK, et al. Long-term effects of finasteride on prostate cancer mortality. N Engl J Med. 2019 Jan 24;380(4):393-4.
http://www.ncbi.nlm.nih.gov/pubmed/30673548?tool=bestpractice.com
However, concerns exist about increased risk of high-grade tumors.
One population-based cohort study reported that men treated with 5-alpha-reductase inhibitors for >2 years had a decreased risk of prostate cancer mortality compared with men who did not receive treatment. However, the men receiving treatment underwent more prostate-specific antigen (PSA) testing and biopsies than the unexposed group, which may have had an impact on the survival difference.[41]Björnebo L, Nordström T, Discacciati A, et al. Association of 5α-reductase inhibitors with prostate cancer mortality. JAMA Oncol. 2022 Jul 1;8(7):1019-26.
https://jamanetwork.com/journals/jamaoncology/fullarticle/2792528
http://www.ncbi.nlm.nih.gov/pubmed/35587340?tool=bestpractice.com
No statistically significant differences were seen in all-cause mortality.
The impact of 5-alpha-reductase inhibitors on absolute or relative rates of prostate cancer in men who are not being regularly screened is not clear. 5-alpha-reductase inhibitors suppress PSA levels, which may lead to misinterpretation of PSA values and possible delays in diagnosis and poorer outcomes.[42]Sarkar RR, Parsons JK, Bryant AK, et al. Association of treatment with 5α-reductase inhibitors with time to diagnosis and mortality in prostate cancer. JAMA Intern Med. 2019 Jun 1;179(6):812-9.
https://www.doi.org/10.1001/jamainternmed.2019.0280
http://www.ncbi.nlm.nih.gov/pubmed/31058923?tool=bestpractice.com
Low-fat diet
A low-fat diet may help reduce the risk of developing prostate cancer. In one systematic review and meta-analysis of randomized and observational studies, soy foods and their isoflavones (genistein and daidzein) were significantly associated with a reduced risk of prostate cancer.[43]Applegate CC, Rowles JL, Ranard KM, et al. Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis. Nutrients. 2018 Jan 4;10(1):40.
http://www.ncbi.nlm.nih.gov/pubmed/29300347?tool=bestpractice.com
Limitations of the review, for example inclusion of studies that rely on dietary recall and presence of potentially confounding variables, necessitate interpreting the results with caution. Further research is required.
Vitamins and dietary supplements
There is no evidence that vitamin supplements C and E or selenium reduce the risk of prostate cancer.[44]Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: The physicians' health study II randomized controlled trial. JAMA. 2009 Jan 7;301(1):52-62.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774210
http://www.ncbi.nlm.nih.gov/pubmed/19066368?tool=bestpractice.com
[45]Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12;306(14):1549-56.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169010
http://www.ncbi.nlm.nih.gov/pubmed/21990298?tool=bestpractice.com
[46]Lippman SMK, Parnes HLM, III, JDC, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009 Jan 7;301(1):39-51.
http://www.ncbi.nlm.nih.gov/pubmed/19066370?tool=bestpractice.com
[47]Jiang L, Yang KH, Tian JH, et al. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials. Nutr Cancer. 2010;62(6):719-27.
http://www.ncbi.nlm.nih.gov/pubmed/20661819?tool=bestpractice.com
[48]Vinceti M, Filippini T, Del Giovane C, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018 Jan 29;(1):CD005195.
http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD005195.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/29376219?tool=bestpractice.com
[
]
Can selenium supplementation reduce the incidence of cancer in adults?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.2063/fullShow me the answer Similarly, multivitamins have not been shown to reduce the risk of prostate cancer.[49]Gaziano JM, Sesso HD, Christen WG, et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2012 Nov 14;308(18):1871-80.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517179
http://www.ncbi.nlm.nih.gov/pubmed/23162860?tool=bestpractice.com
Well-designed trials are warranted to expand knowledge, replicate findings, and further assess the impact of diet and dietary supplement interventions on recurrence and treatment-associated morbidities.[50]Van Patten CL. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol. 2008 Dec;180(6):2314-21.
http://www.ncbi.nlm.nih.gov/pubmed/18930254?tool=bestpractice.com